Related Experiment Video
Updated: Apr 26, 2026
23:56
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
17.7K
Development assistance for neglected tropical diseases: progress since 2009.
Bernhard H Liese1, Natalia Houghton2, Lyubov Teplitskaya2
1Department of International Health, Georgetown University, Washington DC, USA bhl6@georgetown.edu.
International Health
|August 7, 2014
Summary
Funding for neglected tropical diseases (NTDs) has not increased despite increased pharmaceutical donations. Official Development Assistance (ODA) still fails to reflect the burden of these widespread debilitating infections.
Area of Science:
- Global Health
- Infectious Diseases
- Development Economics
Background:
- Neglected tropical diseases (NTDs) affect 2.7 billion people, primarily in low-income settings.
- Recent initiatives by foundations, WHO, and pharmaceutical companies have increased focus on NTDs.
- Previous analysis in 2009 indicated a significant lack of Official Development Assistance (ODA) for NTD control.
Purpose of the Study:
- To analyze changes in ODA for NTDs since 2009.
- To assess the impact of pharmaceutical industry engagement on NTD funding.
- To evaluate if ODA allocation aligns with the global burden of NTDs.
Main Methods:
- Review of ODA data for NTD control projects between 2008 and 2012.
- Analysis of pharmaceutical company contributions, particularly following the 2012 London Declaration.
- Comparison of funding trends with the prevalence and impact of major NTDs.
Main Results:
- Pharmaceutical manufacturers significantly increased engagement through drug donation programs, boosted by the 2012 London Declaration.
- Despite increased private sector involvement, there was no corresponding rise in ODA for NTDs between 2008 and 2012.
- ODA allocation for NTDs did not increase and continues to underrepresent the diseases' public health importance.
Conclusions:
- While pharmaceutical donations have grown, ODA remains a critical, yet underutilized, resource for NTD control.
- Sustained and increased ODA is necessary to complement private sector efforts and effectively combat NTDs.
- Current ODA levels do not adequately address the significant global health burden posed by neglected tropical diseases.
Related Concept Videos
01:28Pulmonary Tuberculosis V
974
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
974
01:26Methods Of Healthcare Delivery System
3.9K
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
3.9K
01:28International Nursing Organizations II
1.4K
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
1.4K
01:28Infectious Diseases and Their Occurrence
82
Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable...
82
01:31Pulmonary Tuberculosis III
1.7K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.7K
01:43Sustainable Development
12.9K
As the human population continues to grow and use resources, we must be mindful of our planet’s natural limits. Sustainable development provides a pathway to maintain and improve human life now while also ensuring that future generations will have the resources that they need. The long-term success of sustainability efforts rests on understanding the interplay between human actions and ecological systems.
12.9K